Medtronic (NYSE:MDT) PT Lowered to $88.00

Medtronic (NYSE:MDT – Free Report) had its price objective decreased by Truist Financial from $90.00 to $88.00 in a research note published on Friday, Benzinga reports. Truist Financial currently has a hold rating on the medical technology company’s stock. A number of other equities analysts have also recently issued reports on MDT. Royal Bank of […]

Related Keywords

Canada ,Michael Marinaro ,Royal Bank ,Needham Company ,First City Capital Management Inc ,Medtronic Company Profile ,Cetera Advisors ,Medtronic ,Cetera Advisor Networks ,Community Trust Investment Co ,Free Report ,Truist Financial ,Get Free Report ,Advisor Networks ,City Capital Management ,Cardiovascular Portfolio ,Medtronic Daily ,